2024-05-06 23:21:03 ET
Summary
- Illumina is a biotechnology company that provides sequencing and array solutions for genomics and molecular diagnostics.
- Transition into newer NovaSeq X presents attractive growth acceleration opportunity, but it will take time.
- Illumina's revenue growth has been flat or declining, but it consistently generates positive operating cash flow.
Illumina ( ILMN ) is a US biotechnology company that provides sequencing and array solutions for genomics and molecular diagnostics. Its solutions help in advancing disease research and drug development....
Read the full article on Seeking Alpha
For further details see:
Illumina: Expect A Slow Rebound